|
C. Ann Merrifield, age 55, has been a director of the Company since May 1997. Ms. Merrifield has served as President of Genzyme Biosurgery, a division of Genzyme Corporation, a diversified biotechnology company, since 2003, and was its Executive Vice President from 2001-2003. From 1996 to 2001, she served as President of Genzyme Genetics (also a division of Genzyme Corporation). Ms. Merrifield was a partner at Bain & Company, a global strategy firm from 1987 to 1992. She currently also serves as a Trustee for MassMutual Premier Funds and MML Series Investment Fund II. | 